Investigation into the molecular mechanisms of NR1D1 and NR2E3 may provide insights into the unique features of choroidal and optic nerve invasion in RB and lead to the development of novel therapeutic targets for RB treatment. The gene discussed is NR1D1; the disease is retinoblastoma.